Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells*

The PR-A and PR-B isoforms of progesterone receptors (PR) have different physiological functions, and their ratio varies widely in breast cancers. To determine whether the two PR regulate different genes, we used human breast cancer cell lines engineered to express one or the other isoform. Cells were treated with progesterone in triplicate, time-separated experiments, allowing statistical analyses of microarray gene expression data. Of 94 progesterone-regulated genes, 65 are uniquely regulated by PR-B, 4 uniquely by PR-A, and only 25 by both. Almost half the genes encode proteins that are membrane-bound or involved in membrane-initiated signaling. We also find an important set of progesterone-regulated genes involved in mammary gland development and/or implicated in breast cancer. This first, large scale study of PR gene regulation has important implications for the measurement of PR in breast cancers and for the many clinical uses of synthetic progestins. It suggests that it is important to distinguish between the two isoforms in breast cancers and that isoform-specific genes can be used to screen for ligands that selectively modulate the activity of PR-A or PR-B. Additionally, use of natural target genes, rather than “consensus” response elements, for transcription studies should improve our understanding of steroid hormone action.

[1]  M. Barcellos-Hoff,et al.  Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. DeMayo,et al.  Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. , 2000, Science.

[3]  K. Horwitz,et al.  Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. E. Ruaro,et al.  Gas6 Induces Growth, β-Catenin Stabilization, and T-Cell Factor Transcriptional Activation in Contact-Inhibited C57 Mammary Cells , 2001, Molecular and Cellular Biology.

[5]  H. Gronemeyer,et al.  A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. , 1992, The Journal of biological chemistry.

[6]  T. Dale,et al.  Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. , 1996, Development.

[7]  Brian Raught,et al.  C/EBPβ, but not C/EBPα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland , 1998 .

[8]  L. Hennighausen,et al.  Stat5a is mandatory for adult mammary gland development and lactogenesis. , 1997, Genes & development.

[9]  J. A. Hamilton,et al.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. , 1993, Molecular and cellular biology.

[10]  C. Clarke,et al.  Detection of progesterone receptor forms A and B by immunohistochemical analysis , 2001, Journal of clinical pathology.

[11]  G. Landes,et al.  Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. , 1999, Cancer research.

[12]  G. Kimmick,et al.  Endocrine therapy in metastatic breast cancer. , 1998, Cancer treatment and research.

[13]  T. Archer,et al.  Regulation of 11β-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  E. Attar,et al.  GAS6 Induces Axl-mediated Chemotaxis of Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.

[15]  L. Hennighausen,et al.  The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. , 1998, Genes & development.

[16]  M. Dowsett,et al.  BCAR1/p130Cas expression in untreated and acquired tamoxifen‐resistant human breast carcinomas , 2000, International journal of cancer.

[17]  N. Weigel,et al.  Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  R. Cardiff,et al.  Impact of progesterone receptor on cell-fate decisions during mammary gland development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P Chambon,et al.  Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. , 1990, The EMBO journal.

[20]  W. McGuire,et al.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. , 1978, The Journal of biological chemistry.

[21]  K. Horwitz,et al.  Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. , 1993, The Journal of biological chemistry.

[22]  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000 .

[23]  B. O’Malley,et al.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. , 1995, Genes & development.

[24]  W. Coleman,et al.  Age-dependent regulation of the tumorigenic potential of neoplastically transformed rat liver epithelial cells by the liver microenvironment. , 1994, Cancer research.

[25]  T. Tamaya,et al.  Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  K. Horwitz,et al.  Convergence of Progesterone with Growth Factor and Cytokine Signaling in Breast Cancer , 1998, The Journal of Biological Chemistry.

[27]  A. Howell,et al.  The primary use of endocrine therapies. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[28]  J. Graham,et al.  Characterization of progesterone receptor A and B expression in human breast cancer. , 1995, Cancer research.

[29]  K. Horwitz,et al.  Transcriptional Hyperactivity of Human Progesterone Receptors Is Coupled to Their Ligand-Dependent Down-Regulation by Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Serine 294 , 2001, Molecular and Cellular Biology.

[30]  C. Daniel,et al.  Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial-stromal interactions. , 1996, Developmental biology.

[31]  E. Vegeto,et al.  The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional acitivity , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  T. Löning,et al.  Progesterone Receptor Isoforms, PR-B and PR-A, in Breast Cancer: Correlations with Clinicopathologic Tumor Parameters and Expression of AP-1 Factors , 2001, Hormone Research in Paediatrics.

[33]  L. Hermo,et al.  Striated anchoring fibrils‐anchoring plaque complexes and their relation to hemidesmosomes of myoepithelial and secretory cells in mammary glands of lactating rats , 1993, The Anatomical record.

[34]  C. Lange,et al.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Baron,et al.  Cytoskeleton-dependent tyrosine phosphorylation of the p130(Cas) family member HEF1 downstream of the G protein-coupled calcitonin receptor. Calcitonin induces the association of HEF1, paxillin, and focal adhesion kinase. , 1999, The Journal of biological chemistry.

[36]  J. Foekens,et al.  Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment. , 2000, Journal of the National Cancer Institute.

[37]  C. Clarke,et al.  Progestin-mediated changes in progesterone receptor forms in the normal human endometrium. , 1988, Endocrinology.

[38]  M. Kulomaa,et al.  Steroid hormone regulation of the gene encoding the chicken heat shock protein hsp 108. , 1987, The Journal of biological chemistry.

[39]  K. Horwitz,et al.  Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. , 1993, Molecular endocrinology.

[40]  S. Nakamura,et al.  Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration , 2000, British Journal of Cancer.

[41]  R. Kitazawa,et al.  Identification of regulatory elements of human alpha 6 integrin subunit gene. , 1997, Biochemical and biophysical research communications.

[42]  J. Ruppert,et al.  Increase of GKLF messenger RNA and protein expression during progression of breast cancer. , 2000, Cancer research.

[43]  Zhiping Zhang,et al.  Estrogen receptor α and estrogen receptor-related receptor α1 compete for binding and coactivator , 2001, Molecular and Cellular Endocrinology.

[44]  F. Halberg,et al.  Circannual rhythms in steroid receptor concentration and nuclear binding in the chick oviduct. , 1980, Endocrinology.

[45]  S. Tsao,et al.  Downregulation of hemidesmosomal proteins in nasopharyngeal carcinoma cells. , 2001, Cancer letters.

[46]  C. Clarke,et al.  Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. , 2000, Human reproduction.

[47]  McGuire Wl,et al.  Hormone receptors: their role in predicting prognosis and response to endocrine therapy. , 1978, Seminars in oncology.

[48]  E. Weiderpass,et al.  Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacement , 1999, Cancer Causes & Control.

[49]  J. Francis,et al.  Urinary tissue factor levels in patients with breast and colorectal cancer , 1999, The Journal of pathology.

[50]  K. Horwitz,et al.  Progestin action and progesterone receptor structure in human breast cancer: a review. , 1985, Recent progress in hormone research.

[51]  A. Nozawa,et al.  The ontogeny of gene expression of progestin receptors in the female rat brain , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[52]  J. Russo,et al.  S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. , 2000, International journal of oncology.

[53]  K. Horwitz,et al.  An N-terminal Inhibitory Function, IF, Suppresses Transcription by the A-isoform but Not the B-isoform of Human Progesterone Receptors* , 1998, The Journal of Biological Chemistry.

[54]  J. Ragoussis,et al.  Characterization and mapping of the human SOX4 gene , 2004, Mammalian Genome.

[55]  K. Horwitz,et al.  Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance , 1982, Cell.

[56]  T. Katsumoto,et al.  Accumulation of cholesterol and GM2 ganglioside in cells cultured in the presence of progesterone: an implication for the basic defect in Niemann-Pick disease type C , 1998, Brain and Development.

[57]  K. Horwitz,et al.  Mapping the Unique Activation Function 3 in the Progesterone B-receptor Upstream Segment , 2001, The Journal of Biological Chemistry.

[58]  W. McGuire,et al.  Predicting response to endocrine therapy in human breast cancer: a hypothesis. , 1975, Science.

[59]  S. Weitzman,et al.  Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells. , 1995, The American journal of pathology.

[60]  T. Spelsberg,et al.  Nonfunctioning progesterone receptors in the developed oviducts from estrogen-withdrawn immature chicks and in aged nonlaying hens. , 1982, Endocrinology.

[61]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.